You just read:

Inovio Pharmaceuticals' Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial

News provided by

Inovio Pharmaceuticals Inc.

Feb 02, 2011, 04:00 ET